Search Results - "Frame, David G"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
  2. 2
  3. 3

    Adjustments to pharmacologic therapies for hemophagocytic lymphohistiocytosis while on extracorporeal support by Weyand, Angela C., Barbaro, Ryan P., Walkovich, Kelly J., Frame, David G.

    Published in Pediatric blood & cancer (01-06-2021)
    “…Hemophagocytic lymphohistiocytosis (HLH) is an immune dysregulatory syndrome characterized by severe inflammation and end‐organ damage. Due to significant…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Best practice management of CINV in oncology patients: I. Physiology and treatment of CINV. Multiple neurotransmitters and receptors and the need for combination therapeutic approaches by Frame, David G

    Published in The Journal of supportive oncology (01-03-2010)
    “…Chemotherapy-induced nausea and vomiting (CINV) involves multiple neurotransmitter and receptor systems; thus, its optimal treatment is likely to require a…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Treatment of Dyslipidemia in Allogeneic Hematopoietic Stem Cell Transplant Patients by Marini, Bernard Lawrence, Choi, Sung Won, Byersdorfer, Craig Alan, Cronin, Simon, Frame, David G

    “…Abstract As survival rates in allogeneic hematopoietic stem cell transplantation (HSCT) continue to improve, attention to long-term complications, including…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Baseline body mass index among children and adults undergoing allogeneic hematopoietic cell transplantation: clinical characteristics and outcomes by Gleimer, M, Li, Y, Chang, L, Paczesny, S, Hanauer, D A, Frame, D G, Byersdorfer, C A, Reddy, P R, Braun, T M, Choi, S W

    Published in Bone marrow transplantation (Basingstoke) (01-03-2015)
    “…Obesity is an important public health problem that may influence the outcomes of hematopoietic cell transplantation (HCT). We studied 898 children and adults…”
    Get full text
    Journal Article
  11. 11

    Efficacy of ondansetron and prochlorperazine for the prevention of postoperative nausea and vomiting after total hip replacement or total knee replacement procedures: a randomized, double-blind, comparative trial by Chen, J J, Frame, D G, White, T J

    Published in Archives of internal medicine (1960) (26-10-1998)
    “…Limited data are available on the efficacy of ondansetron hydrochloride compared with prochlorperazine maleate for the treatment of postoperative nausea and…”
    Get more information
    Journal Article
  12. 12